Sex Transm Dis. 2018 Feb;45(2):92-95. doi: 10.1097/OLQ.0000000000000707.
Real-time polymerase chain reaction (PCR) assays to detect antimicrobial resistance-associated mutations were tested on Neisseria gonorrhoeae-positive clinical samples with matched isolates. Of the nucleic acid amplification tests/cultures, 87.7% (64/73), 98.6% (72/73), and 98.4% (62/63) predicted cephalosporin, ciprofloxacin, and azithromycin susceptibilities, respectively. N. gonorrhoeae multiantigen sequence type was correctly predicted for 98.7% (79/80), and 13 of 58 N. gonorrhoeae-negative specimens showed false-positive results.
对淋病奈瑟菌阳性临床样本及其匹配分离株进行了检测抗菌药物耐药相关突变的实时聚合酶链反应(PCR)检测。在核酸扩增检测/培养中,分别有 87.7%(64/73)、98.6%(72/73)和 98.4%(62/63)预测了头孢菌素、环丙沙星和阿奇霉素的敏感性。淋病奈瑟菌多抗原序列型的正确预测率为 98.7%(79/80),58 份淋病奈瑟菌阴性标本中有 13 份出现假阳性结果。